Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GLOBAL BLOOD THERAPS

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 47
  • 0 comments

FDA approve VOXELOTOR

Comment Full text

NEUROCRINE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 44
  • 0 comments

FDA approve VALBENAZINE TOSYLATE

Comment Full text

ABBVIE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 46
  • 0 comments

FDA approve ESCITALOPRAM OXALATE

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 32
  • 0 comments

FDA approve POZELIMAB-BBFG

Comment Full text

I 3 PHARMS

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 33
  • 0 comments

FDA approve MARAVIROC

Comment Full text

ABBVIE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 43
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

LILLY

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 29
  • 0 comments

FDA approve DULOXETINE HYDROCHLORIDE

Comment Full text

ABBVIE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 48
  • 0 comments

FDA approve VILAZODONE HYDROCHLORIDE

Comment Full text

ABBVIE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 45
  • 0 comments

FDA approve MILNACIPRAN HYDROCHLORIDE

Comment Full text

UPJOHN

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 46
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 706
  • 707
  • 708
  • 709
  • 710
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5288)
  • SEC News(250707)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150009)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin